Cargando…

Treatment-emergent adverse events after infusion of adherent stem cells: the MiSOT-I score for solid organ transplantation

BACKGROUND: Cellular therapy after organ transplantation is emerging as an intriguing strategy to achieve dose reduction of classical immunosuppressive pharmacotherapy. Here, we introduce a new scoring system to assess treatment-emergent adverse events (TEAEs) of adherent stem cell therapies in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dillmann, Johannes, Popp, Felix C, Fillenberg, Barbara, Zeman, Florian, Eggenhofer, Elke, Farkas, Stefan, Scherer, Marcus N, Koller, Michael, Geissler, Edward K, Deans, Robert, Ladenheim, Deborah, Loss, Martin, Schlitt, Hans J, Dahlke, Marc H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543274/ https://www.ncbi.nlm.nih.gov/pubmed/23151227 http://dx.doi.org/10.1186/1745-6215-13-211

Ejemplares similares

Safety and feasibility of third-party multipotent adult progenitor cells for immunomodulation therapy after liver transplantation--a phase I study (MISOT-I)
por: Popp, Felix C, et al.
Publicado: (2011)

Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion
por: Eggenhofer, E., et al.
Publicado: (2012)

COVID-19 in SOT versus non-SOT
por: Allam, Sridhar R., et al.
Publicado: (2021)

TXG at SOT.
por: Potera, Carol
Publicado: (2003)

Rio Sot /
por: Leonov, Leonid, 1899-1994
Publicado: (1981)

Sot manual /
por: Monk, Robert, et al.
Publicado: (2016)

Steatotic Livers Are More Susceptible to Ischemia Reperfusion Damage after Transplantation and Show Increased γδ T Cell Infiltration
por: Eggenhofer, Elke, et al.
Publicado: (2021)

Augmenter of Liver Regeneration Reduces Ischemia Reperfusion Injury by Less Chemokine Expression, Gr-1 Infiltration and Oxidative Stress
por: Weiss, Thomas S., et al.
Publicado: (2019)

1898. Clinical Characteristics of Patients With Solid-Organ Transplantation (SOT) and Norovirus (NV) Infections
por: König, Verena, et al.
Publicado: (2018)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer
por: Piso, Pompiliu, et al.
Publicado: (2004)

Study Protocol: A Pilot Study to Determine the Safety and Efficacy of Induction-Therapy, De Novo MPA and Delayed mTOR-Inhibition in Liver Transplant Recipients with Impaired Renal Function. PATRON-Study
por: Schnitzbauer, Andreas A, et al.
Publicado: (2010)

Outpatient Antimicrobial Stewardship Intervention Targeting Cytomegalovirus (CMV) Viremia in Solid Organ Transplant (SOT) Recipients
por: Wang, Nan, et al.
Publicado: (2017)

1393. Tuberculosis (TB) After Solid-organ Transplant (SOT) and Hematopoietic Stem Cell Transplant (HSCT)
por: Peña-Puga, Cecilia F, et al.
Publicado: (2019)

The Life and Fate of Mesenchymal Stem Cells
por: Eggenhofer, Elke, et al.
Publicado: (2014)

2116. Long-term (2-year) outcomes and complications of COVID-19 in solid organ transplant (SOT) recipients
por: Burack, Daniel, et al.
Publicado: (2022)

SOT at 50: A Proud Legacy, A Vibrant Future
por: Birnbaum, Linda S.
Publicado: (2011)

Postoperative cellular stress in the kidney is associated with an early systemic γδ T-cell immune cell response
por: Göcze, Ivan, et al.
Publicado: (2018)

582. Safety and Efficacy of High-Dose Ganciclovir versus Standard Dosing for Cytomegalovirus Viremia in Solid Organ Transplant (SOT) Recipients
por: Fitzmaurice, Mary Grace, et al.
Publicado: (2020)

Covid-19 in liver transplant recipients: the French SOT COVID registry
por: Dumortier, Jérôme, et al.
Publicado: (2021)

A Comprehensive Study of Temperature and Its Effects in SOT-MRAM Devices
por: Hadámek, Tomáš, et al.
Publicado: (2023)

Outcomes of SOT Recipients With COVID-19 in Different Eras of COVID-19 Therapeutics
por: Sait, Afrah S., et al.
Publicado: (2021)

1597. Risk Factors for Failure of Primary (Val)ganciclovir Prophylaxis Against Cytomegalovirus (CMV) Infection and Disease in Solid Organ Transplant (SOT) Recipients
por: Khurana, Mark Poulsen, et al.
Publicado: (2018)

1564. Lower Rates of Epstein–Barr Virus (EBV) Viremia in Pediatric Solid Organ Transplant (SOT) Recipients Who Received Valganciclovir Prophylaxis
por: Moulton, Elizabeth A, et al.
Publicado: (2018)

2670. Clostridioides difficile Infection (CDI) in Solid-Organ (SOT) and Hematopoietic Stem Cell Transplant (HCT) Recipients: A Prospective Multinational Study
por: Blumberg, Emily, et al.
Publicado: (2019)

Putting ethics and clinical decision making before politics: requiring COVID-19 immunization for Solid Organ Transplantation (SOT) Candidates and their Support Team
por: Kuczewski, Mark, et al.
Publicado: (2022)

CAF Proteins Help SOT1 Regulate the Stability of Chloroplast ndhA Transcripts
por: Li, Xiuming, et al.
Publicado: (2021)

340. Outcomes of COVID-19 in Hospitalized SOT Recipients: Experence in Colombia, South America
por: Rosso, Fernando, et al.
Publicado: (2021)

Retrograde stapling of a free cervical jejunal interposition graft: a technical innovation and case report
por: Hackl, Christina, et al.
Publicado: (2014)

226. Nine-year Survey of Bloodstream Infections (BSIs) across Six Types of Solid-organ Transplant (SOT) at a Large University Medical Center
por: Buehrle, Deanna, et al.
Publicado: (2019)

Is It Feasible to Use CMV-Specific T-Cell Adoptive Transfer as Treatment Against Infection in SOT Recipients?
por: García-Ríos, Estéfani, et al.
Publicado: (2021)

Outcome after polytrauma in a certified trauma network: comparing standard vs. maximum care facilities concept of the study and study protocol (POLYQUALY)
por: Koller, Michael, et al.
Publicado: (2016)

SUN-165 The Largest Single-Center Experience of GLP-1 Receptor Agonists as a Safe and Effective Agent for the Management of Diabetes in Solid Organ Transplant (SOT) Recipients
por: Singh, Priyamvada, et al.
Publicado: (2019)

Evaluation of Rapid Diagnostics for Plasmodium falciparum and P. vivax in Mae Sot Malaria Endemic Area, Thailand
por: Chaijaroenkul, Wanna, et al.
Publicado: (2011)

Identification and characterization analysis of sulfotransferases (SOTs) gene family in cotton (Gossypium) and its involvement in fiber development
por: Wang, Liyuan, et al.
Publicado: (2019)

Theoretical Study of Field-Free Switching in PMA-MTJ Using Combined Injection of STT and SOT Currents
por: Wasef, Shaik, et al.
Publicado: (2021)

Supportive Oligonucleotide Therapy (SOT) as a Potential Treatment for Viral Infections and Lyme Disease: Preliminary Results
por: Apostolou, Panagiotis, et al.
Publicado: (2022)

Accept or refuse? Factors influencing the decision-making of transplant surgeons who are offered a pancreas: results of a qualitative study
por: Loss, Julika, et al.
Publicado: (2013)

Immune function as predictor of infectious complications and clinical outcome in patients undergoing solid organ transplantation (the ImmuneMo:SOT study): a prospective non-interventional observational trial
por: Drabe, Camilla Heldbjerg, et al.
Publicado: (2019)

2667. Does Ceftazidime–Avibactam (CAZ-AVI) Improve Short- and Long-Term Outcomes Among Solid-Organ Transplant (SOT) Recipients with Carbapenem-Resistant Enterobacteriaceae (CRE) Infections?
por: Sun, Jonathan, et al.
Publicado: (2019)

Head-to-Head Comparison of Response Rates to the Two mRNA SARS-CοV-2 Vaccines in a Large Cohort of Solid Organ Transplant (SOT) Recipients
por: Marinaki, Smaragdi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jnjceitdh24tvp75muj75qc4vs